Applying Item Response Theory to Improve Patient Reported Outcome Use in Dermatology Clinical Practice
Applying Item Response Theory to Improve Patient Reported Outcome Use in Dermatology Clinical Practice
批准号:
10655603
负责人:
John Barbieri
金额:
$17.39万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30
关键词:
AcneAddressAdvisory CommitteesAffectAreaAtopic DermatitisAwardCalibrationCaringClient satisfactionClinicClinicalClinical ResearchComputersCost effectiveness researchDataDermatologyDevelopmentDevelopment PlansDiseaseElectronic Health RecordEnvironmentFacultyFocus GroupsFoundationsGoalsHealth Services ResearchHealth systemHealthcareHospitalsIndividualInformation SystemsKnowledgeLearningMeasurementMeasuresMentored Patient-Oriented Research Career Development AwardMentorsMethodsModernizationNatureOutcomeOutcome MeasureOutcomes and Health Services ResearchPatient CarePatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPersonal SatisfactionPersonsPhysical FunctionPhysiciansPositioning AttributePropertyPsoriasisPsychometricsQualitative ResearchQuality of CareQuality of lifeReportingResearchResourcesReview LiteratureScientistSelection for TreatmentsSeverity of illnessSkinSurveysSymptomsTechniquesTestingTimeTrainingUnited StatesValidationVisitWomanWorkcareercareer developmentchronic inflammatory skinclinical careclinical practicecomparative effectivenessconcept mappingeconomic costemotional functioningexperiencefield studyimprovedindexinginnovationinsightinstrumentknowledge basemembernovelpatient orientedpsychosocialresearch and developmentresponseskillsskin disordersoundsymptom managementteledermatologytenure tracktheoriestreatment response
中文摘要
项目摘要/摘要
研究:虽然有效地衡量患者对他们的疾病及其治疗的看法提供了
免费提供客观疾病严重程度的信息,患者报告的结果捕捉到了活着的人
慢性炎症性皮肤病的经验很少在皮肤科的常规实践中使用。项目响应
理论技术可以在临床上更有效地管理患者报告的结果,这
可以解决实施这些措施的时间等障碍。这项研究的目的是:1.确定优先顺序
对患有慢性炎症性皮肤病的个人最有意义的结果域,如
痤疮、牛皮癣和特应性皮炎;2.评估一名新患者的内容有效性--报道的结果
测量信息系统(PROIS)配置文件测量这些领域;3.现场测试和评估
一个新的PROMIS档案的有效性,以捕捉慢性炎症性皮肤病的生活经验。这个
这项K23奖励计划的总体目标是改善慢性炎症性皮肤患者的护理
通过制定一个实际的患者报告的结果来衡量这些皮肤的生活体验
这将使常规临床护理中更多地使用患者报告的结果。
候选人:Barbieri博士的长期职业目标是成为一名独立的、以病人为中心的医生--
科学家,重点关注慢性炎症性皮肤病、患者报告的结果和健康服务
研究。他之前的培训为他提供了这些领域的基础背景。
环境:在获奖期间,Barbieri博士将把80%的时间用于临床研究,20%的时间用于
痤疮、特应性皮炎等慢性炎症性皮肤病患者的临床护理
银屑病。马戈利斯博士和普西奇博士是候选人的主要导师,他们直接监督了
许多成功的初级教员和Barbieri博士将从他的经验和热情中受益
培养初级科学家的职业生涯。布里格姆妇女医院提供丰富的培训
环境,包括临床研究创新和试验股提供的资源和专门知识
(CUReIT)和患者报告的结果、价值和体验(Proven)中心。结合了
皮肤科、马戈利斯医生和普西奇医生的知识和专业知识
实验室,这些机会将提供一个无与伦比的机会开始作为内科科学家的职业生涯。
职业发展:在他的顾问委员会的支持下,Barbieri博士的培训将集中在
先进的心理测量技术和定性研究,建立了强大的尊重知识基础
到患者报告的结果开发和验证。完成拟议的研究和职业生涯
发展计划将给予Barbieri博士知识和技能,以实现科学独立、过渡
终身教职跟踪教师职位,并为以患者为导向的临床研究职业生涯奠定坚实的基础。
英文摘要
Project Summary/Abstract
Research: While effective measurement of the patient’s perspective on their illness and its treatment provides
complimentary information to objective disease severity, patient-reported outcomes capturing the lived
experience of chronic inflammatory skin disease are rarely used in routine dermatology practice. Item response
theory techniques can enable more efficient administration of patient-reported outcomes in the clinic, which
can address barriers such as time to administer these measures. The purpose of this study is to 1. prioritize
the outcome domains that are most meaningful to individuals with chronic inflammatory skin diseases such as
acne, psoriasis, and atopic dermatitis; 2. evaluate the content validity of a novel Patient-Reported Outcomes
Measurement Information System (PROMIS) profile measuring these domains; 3. field test and evaluate the
validity of a novel PROMIS profile to capture the lived experience of chronic inflammatory skin disease. The
overall objectives of this K23 award proposal are to improve the care of patients with chronic inflammatory skin
diseases by developing a practical patient-reported outcome to measure the lived experience of these skin
diseases, which will enable increased use of patient-reported outcomes in routine clinical care.
Candidate: Dr. Barbieri’s long-term career goal is to become an independent, patient-oriented physician-
scientist, with a focus on chronic inflammatory skin diseases, patient-reported outcomes, and health services
research. His prior training has provided him with a foundational background in these areas.
Environment: During the award period Dr. Barbieri will devote 80% of his time to clinical research and 20% to
the clinical care of patients with chronic inflammatory skin disease such as acne, atopic dermatitis, and
psoriasis. Dr. Margolis and Dr. Pusic, the candidate’s primary mentors, have directly supervised the training of
numerous successful junior faculty members and Dr. Barbieri will benefit from his experience and enthusiasm
for cultivating the careers of junior scientists. The Brigham and Women’s Hospital offers a rich training
environment, including resources and expertise available in the Clinical Unit for Research Innovation and Trials
(CUReIT) and Patient-Reported Outcomes, Value & Experience (PROVE) Center. Combined with the
knowledge and expertise available in the Department of Dermatology and in Dr. Margolis’s and Dr. Pusic’s
labs, these opportunities will provide an unparalleled opportunity to begin a career as a physician scientist.
Career Development: With the support of his advisory committee, Dr. Barbieri’s training will focus on
advanced psychometric techniques and qualitative research to develop a strong knowledge base with respect
to patient-reported outcome development and validation. Completion of the proposed research and career
development plan will give Dr. Barbieri the knowledge and skills to achieve scientific independence, transition
to a tenure track faculty position, and build a strong foundation for a career in patient-oriented clinical research.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.
螺内酯对女性寻常痤疮 (SAFA) 试验的有效性:一个受到严格评价的话题。
DOI:
10.1093/bjd/ljad270
发表时间:
2023
期刊:
The British journal of dermatology
影响因子:
--
作者:
[Shields,Ali, Barbieri,JohnS]
通讯作者:
Barbieri,JohnS
Isotretinoin exposure does not appear to be associated with risk of adverse male sexual health outcomes in acne patients.
异维A酸暴露似乎与痤疮患者男性性健康不良后果的风险无关。
DOI:
10.1111/ijd.16865
发表时间:
2024
期刊:
International journal of dermatology
影响因子:
3.6
作者:
[Thang,ChristopherJ, Garate,David, Golovko,George, Barbieri,JohnS]
通讯作者:
Barbieri,JohnS
The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review.
口服营养保健品作为辅助治疗减少异维A酸副作用的作用:系统评价。
DOI:
10.1016/j.jaad.2023.10.037
发表时间:
2024
期刊:
Journal of the American Academy of Dermatology
影响因子:
13.8
作者:
[Shields,Ali, Ly,Sophia, Wafae,Bruna, Chang,Yu-Feng, Manjaly,Priya, Archila,Marjorie, Heinrich,Christina, Drake,Lara, Mostaghimi,Arash, Barbieri,JohnS]
通讯作者:
Barbieri,JohnS
Content analysis of health-related quality-of-life patient-reported outcome measures used in patients with atopic dermatitis.
对特应性皮炎患者使用的与健康相关的生活质量患者报告的结果测量的内容分析。
DOI:
10.1016/j.jaad.2023.05.069
发表时间:
2023
期刊:
Journal of the American Academy of Dermatology
影响因子:
13.8
作者:
[Shields,Ali, Yoon,Jaewon, Barbieri,JohnS]
通讯作者:
Barbieri,JohnS
Temporal Trends in the Use of Systemic Medications for Acne From 2017 to 2020.
2017 年至 2020 年痤疮全身药物使用的时间趋势。
DOI:
10.1001/jamadermatol.2023.2363
发表时间:
2023
期刊:
JAMA dermatology
影响因子:
10.9
作者:
[Barbieri,JohnS]
通讯作者:
Barbieri,JohnS
共 9 条
Applying Item Response Theory to Improve Patient Reported Outcome Use in Dermatology Clinical Practice
-
批准号:10524835
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2022
-
负责人:John Barbieri
-
依托单位:
海外基金